From: Primary small cell carcinoma of the esophagus: clinicopathological study of 44 cases
Variable | No.of patients | % |
---|---|---|
Gender | Â | Â |
Male | 33 | 75.0 |
Female | 11 | 25.0 |
Age | Â | Â |
>60 | 15 | 34.1 |
<=60 | 29 | 65.9 |
PS score | Â | Â |
>1 | 4 | 9.1 |
<=1 | 40 | 90.9 |
Tumor length(39 available) | Â | Â |
> = 5 cm | 21 | 53.8 |
<5Â cm | 18 | 46.2 |
Tumor location | Â | Â |
Upper thoracic segment | 7 | 15.9 |
Middle thoracic segment | 22 | 50.0 |
Lower thoracic segment | 15 | 34.1 |
AJCC stage(43 available) | Â | Â |
I/II | 19 | 44.2 |
III/IV T classification(40 available) | 24 | 55.8 |
T < =2 | 20 | 45.5 |
T > 2 | 20 | 45.5 |
N classification(42 available) | Â | Â |
N0 | 16 | 36.4 |
N+ | 26 | 59.1 |
M classification(43 available) | Â | Â |
M0 | 33 | 75.0 |
M1 | 10 | 22.7 |
Treatment approach | Â | Â |
Surgery | Â | Â |
No | 11 | 25.0 |
Yes | 33 | 75.0 |
Chemotherapy | Â | Â |
No | 16 | 36.4 |
Yes | 28 | 63.6 |
Radiotherapy | Â | Â |
No | 16 | 36.4 |
Yes | 28 | 63.6 |
Lgr5 expression | Â | Â |
Low | 23 | 52.3 |
High | 21 | 47.7 |